Cartesian Therapeutics, Inc.

US$7.53As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RNACHealthcare
Country USA
PE (Fwd) •••
TSR 3Y CAGR (43.57%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.76
PE TTM —
TSR TTM (7.83%)
Mkt cap US$229.7M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.82
17.19%
(18.95%)
Hold 9|6|6|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.09
0.08
0.09
0.09
26.83%
23.14%
26.79%
17.68%
Revenue$M
26.21
26.55
25.86
26.84
14.14%
9.75%
1.26%
(0.59%)
Peers (US$229.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.111
0.408
0.389
EBIT/Intx
0.802
0.334
0.355
Own earn%
(14.40)
19.37
17.98
Sh yield%
42.03
54.07
52.08
Owners
Insiders/Inst%
14.24
27.92
Short interest%
4.21
SBC / revenue%
3.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
5–11
$1 testx
16.6
Incr. ROIC%
3